ML-109 is a potent and full thyroid stimulating hormone receptor (TSHR) agonist with EC50 of 40 nM.

TSHR antagonist S37是一种选择性甲状腺刺激激素受体（TSHR）拮抗剂，能够有效抑制TSHR的活性，在甲状腺疾病研究中具有潜力。

NCGC00229600 是 TSHR 的变构反向激动剂，能够抑制 TSH 及其在 Graves 病中内源表达的 TSHRs 的抗体激活。

Teprotumumab是一种人源化IgG1单克隆抗体，通过与IGF1R结合来阻止其与配体结合。Teprotumumab具有用于甲状腺相关眼病研究的潜力。

MS438 is a potent agonist of the TSH receptor (TSHR).

ML224 is a selective TSHR inverse agonist and inhibits TSH-stimulated cAMP production with an IC50 = 2.3 μM.

Org41841 is a partial agonist of both luteinizing hormone/chorionic gonadotropin receptor (LHCGR) and thyroid-stimulating hormone receptor (TSHR) with EC50s of 0.2 and 7.7 μM, respectively.

D3-βArr is a positive allosteric TSH Receptor modulator.